Articles Referencing BSTC

Zacks.com

Company News for May 13, 2013 - Corporate Summary

•    DiamondRock Hospitality Company (NYSE: DRH ) posted first quarter earnings per share of $0.14, ahead of the Zacks Consensus Estimate of $0.09 •  ... Read >>

Zacks.com

Positive Data on BSTC's Xiaflex - Analyst Blog

BioSpecifics Technologies ( BSTC ) recently announced positive top line data from a phase IIa study on Xiaflex for the potential treatment of frozen shoulder syndrome (FSS) in adults.... Read >>

Zacks.com

Standard Review for Auxilium's Drug - Analyst Blog

Auxilium Pharmaceuticals, Inc. ( AUXL ) recently announced that the FDA has accepted its supplemental Biologics License Application (sBLA) for Xiaflex (clostridial collagenase for... Read >>

Kapitall

Merck Reports Strong Q3 Results on Gardasil and Diabetes Med

(Written by Alexander Crawford. Institutional data sourced from Fidelity.) At a time of significant restructuring to adapt to generic competition, Merck & Co. ( MRK ) reported an otherwise... Read >>

Kapitall

Biotech Bargains: Biotech Analysts See Buying Opportunities From Selloff

(Written by Alexander Crawford. Current assets and liabilities CAGR, cash and debt data sourced from Screener.co, all other data sourced from Finviz.) The biotech industry often gets... Read >>